The appearance of psoriasis can vary based on the level of melanin, or the pigment that colors our skin. For Black patients or those with darker pigmented skin, lesions may be violet, dark brown ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, particularly in phase III psoriasis trials.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Fact checked by Nick Blackmer Meet the Expert Casey Gallagher, MD, is a board-certified dermatologist and a clinical ...

A decade-long study found that obesity was associated with a significantly increased risk for biologic treatment failure in ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Brian Loew of Inspire highlights the importance of online patient discussions in patients with psoriasis. About 8 in 10 psoriasis patients who use social networks say they do so because they want ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic ...

“For me, psoriatic arthritis is always in the picture. So any and every psoriasis patient I see as a dermatologist, I always question or try to find out whether there are risk factors for ...